Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors

World J Gastroenterol. 2013 Aug 14;19(30):4887-96. doi: 10.3748/wjg.v19.i30.4887.

Abstract

Aim: To evaluate the histopathological findings of type C liver disease to determine risk factors for development of hepatocellular carcinoma (HCC).

Methods: We studied 232 patients, who underwent liver biopsy for type C chronic liver disease between 1992 and 2009, with sustained virological response (SVR) after interferon therapy. The patients were divided into two groups according to the F stage 0 + 1 + 2 group (n = 182) and F3 + 4 group (n = 50). We prospectively observed and compared the incidence of HCC of the patients with SVR in the F0 + 1 + 2 and F3 + 4 groups. Then, the background factors and liver histopathological findings, including the degree of fibrosis, F stage, inflammation, necrosis, bile duct obstruction, fat deposition, and degree of irregular regeneration (IR) of hepatocytes, were correlated with the risk of developing HCC.

Results: HCC developed in three of 182 (1.6%) patients in the F0 + 1 + 2 group, and four of 50 (8.0%) in the F3 + 4 group. The cumulative incidence of HCC in the former group was found to be significantly lower than in the F3 + 4 group (log rank test P = 0.0224). The presence of atypical hepatocytes among IR of hepatocytes in the F3 + 4 group resulted in a higher cumulative incidence of HCC, and was significantly correlated with risk of HCC development (RR = 20.748, 95%CI: 1.335-322.5, P = 0.0303).

Conclusion: Atypical hepatocytes among the histopathological findings of type C liver disease may be an important risk factor for HCC development along with progression of liver fibrosis.

Keywords: Hepatocellular carcinoma; Histopathology of liver biopsy; Irregular regeneration of hepatocytes; Liver fibrosis; Type C chronic liver disease.

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use
  • Biopsy
  • Carcinoma, Hepatocellular / epidemiology
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / virology*
  • Chi-Square Distribution
  • Disease Progression
  • Drug Therapy, Combination
  • Female
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / epidemiology
  • Hepatitis C, Chronic / pathology*
  • Humans
  • Incidence
  • Interferon-alpha / therapeutic use
  • Japan / epidemiology
  • Kaplan-Meier Estimate
  • Liver / drug effects
  • Liver / pathology*
  • Liver / virology
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / epidemiology
  • Liver Cirrhosis / pathology
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / pathology
  • Liver Neoplasms / virology*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Prospective Studies
  • Ribavirin / therapeutic use
  • Risk Assessment
  • Risk Factors
  • Time Factors

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Ribavirin